News Releases - U.S. Senator Amy Klobuchar

Date	Title
9/1/16	Klobuchar on the Drug Category Misclassification of Mylan Pharmaceutical’s EpiPen

Date	Title
8/31/16	Klobuchar, Grassley, Blumenthal Call on the Centers for Medicare & Medicaid Services to Provide Information on the Effect of Mylan’s Price Increases on Government Prescription Drug Costs
8/29/16	Klobuchar Statement on Mylan Pharmaceutical’s Launch of a Generic Version of EpiPen
8/25/16	Klobuchar Statement on Mylan Pharmaceutical Announcement to Expand Existing EpiPen Patient Assistance Programs
8/24/16	Klobuchar, Bipartisan Group of Senators Ask FDA to Account for Any Alternatives to the EpiPen Amid Product Cost Increases
8/22/16	Klobuchar Calls for FTC Investigation of Mylan Pharmaceuticals for Possible Antitrust Violations in Light of Dramatic Price Increase of EpiPen Packs
8/20/16	Klobuchar Calls for Judiciary Hearing and Investigation Into At Least 400 Percent Increase of EpiPen Packs
8/9/16	Following Efforts from Klobuchar, Crapo, and Matsui, EPA Finishes Implementing Bipartisan Legislation Lawmakers Passed to Protect Consumers from Formaldehyde in Wood Products
8/9/16	Klobuchar Statement on AT&T’s $7.8 Million Settlement with FCC to Resolve Cramming Investigation
8/5/16	After Effort from Klobuchar, Franken, Peterson, McCollum, Ellison, and Nolan, the Centers for Medicare and Medicaid Services Withdraw Proposal That Would Have Resulted in $40 Million Cut to Minnesota Hospitals